A Study of Injectable BLB101 and Blincyto® in Adult Participants With R/R CD19+ B-ALL
Clinical trial NCT07723911 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07723911
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-09
- Primary completion
- 2027-10-10
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.